Transcript Highlights:

• We do not perform surgery, treat emergencies, carry controlled substances, or house animals overnight
• substances, or house carry controlled substances, or house animals<00:09:02.640> overnight.
• If that vet wrote a prescription to one person for a controlled substance, then that would have to be
• If that vet wrote a prescription to one person for a controlled substance, then that would have to be
• If that vet wrote a prescription to one person for a controlled substance, then that would have to be

Keywords: 958, all

Summary: The committee first reviewed several Fish and Wildlife regulations. Staff explained amendments to 301 KAR 2:176, 4:112, and 6:030, including updating wildlife control tag language, creating an impoundment agent program for seized wildlife, and clarifying boating safety rules. A member raised a concern about boat wakes near docks, and staff said the commission had recently voted on related changes that were not yet included because the regulation had been filed earlier; those changes would have to come back later. The committee approved the staff amendments without objection. The Board of Veterinary Examiners then presented 201 KAR 16:767, which would require veterinary managers to be physically present during business hours and limit them to five registered facilities. Board representatives said they had tried to meet with affected parties before the hearing but had not reached agreement. A representative for Kentucky Pet IQ argued the rule was written for full-service hospitals and would be impractical for short, limited-service clinics that only provide vaccinations, preventive care, and parasite testing. Members expressed concern about the rule’s impact on veterinary access in underserved areas, and the committee voted to defer the regulation until the next month so the parties could continue negotiating. The committee next considered Transportation Cabinet 601 KAR 9:120, the online insurance verification system, in both ordinary and emergency form. The chair said staff had identified conflicts with a bill passed the prior year and moved to find the regulations deficient. The motion passed on a roll call vote, with six ayes and two pass votes. The committee then found ordinary ABC regulations 804 KAR 12:020 and 12:030 deficient as well, again by six ayes and two pass votes, after noting that the emergency versions had already been found deficient the previous month. Finally, the committee reviewed Cabinet for Health and Family Services 902 KAR 55:110, which would require veterinarians to report dispensed controlled substances to KASPER while exempting administered medications. OIG staff said the rule was meant to align regulation with statute, which includes veterinarians as prescribers, and emphasized that the reporting duty applies to prescriptions, not administration to animals. Some members supported the change as a needed anti-diversion measure, while others worried about implementation burdens and timing. After discussion, the committee found the regulation deficient by a 6-2 vote. The meeting then moved into full review of 922 KAR 1:565, a Department for Community Based Services rule implementing kinship care provisions from Senate Bill 151; staff said it was needed for implementation once funding is available, but a member criticized the two-year delay and the inclusion of language conditioning implementation on funding. A public witness from the Kinship Families Coalition argued the rule should not shift the 120-day application window in a way that could affect federal funding eligibility and urged the committee to reject the regulation as written.

Transcript Highlights:

• substances, often in a so-called meth lab.
• This legislation clearly defines distribution of Class A controlled substances or counterfeit controlled
• More often than not, those who buy these substances are victims of substance use disorder, chronically
• The individuals targeted by this legislation are distributing a Class A controlled substance, which is
• often counterfeit substances like fentanyl, but peddled as a different substance to achieve greater

Keywords: 995, all

Summary: The hearing covered a wide range of Judiciary Committee bills, with much of the testimony focused on criminal justice, public safety, and civil asset forfeiture reform. Several lawmakers and advocates supported bills to increase penalties or create new offenses related to assaults on sports officials, assaults on transit workers, reckless discharge of firearms, fires and explosives, pill press machines, and drug-induced homicide. Testifiers described rising harassment and violence against youth sports officials and transit workers, as well as the fentanyl overdose crisis and the need for stronger tools to prosecute dealers whose conduct leads to death. Supporters of the sports-official and transit-worker bills emphasized declining referee availability and repeated assaults on commuter rail and MBTA workers. District attorneys also backed bills on reckless firearm discharge and fires/explosives, saying current law does not adequately address dangerous conduct that endangers bystanders. The committee also heard testimony on several proposals related to youth diversion and prison mitigation. Supporters of the youth court justice fund bill said youth courts are peer-led diversion programs with strong compliance and low recidivism, and argued for a stable funding source rather than annual earmarks. A representative from Bridgewater supported a prison mitigation fund for municipalities that host state prisons, saying the costs of public safety and emergency services are not fully covered. On gun policy, testimony split between supporters of a bill to ban in-state manufacture of assault-style rifles for civilian sale and opponents or skeptics of other firearm-related measures, including a bill on collateralizing firearms and a bill to increase penalties for drug trafficking combined with illegal firearm offenses. A major portion of the hearing was devoted to civil asset forfeiture reform. Advocates from the ACLU, CPCS, the Boston Bar Association, the Institute for Justice, and others supported bills to increase the burden of proof, improve transparency and reporting, require counsel, and limit or eliminate the current practice of directing forfeiture proceeds to law enforcement. They argued the current system creates perverse incentives, lacks adequate due process, and is insufficiently transparent. District Attorney Paul Tucker defended current forfeiture practices, saying his office has reporting and oversight, uses the funds for investigations and community programs, and warned that reducing forfeiture revenue would hinder crime fighting. No votes or final committee actions were taken during the hearing; the chairs repeatedly thanked witnesses and indicated the bills would remain under consideration.

Transcript Highlights:

• constitutional officers are in control constitutional officers are in control of<00:03:59.120>
• substances that are per se DUI.
• Line eight we've added a substance. And line 10 we've added a substance.
• Most importantly, fentanyl is the substance we've added that is a per se substance now.
• per<00:15:45.040> se controlled substances that are per se controlled substances that are

Keywords: 958, all

Summary: The Senate Judiciary Committee heard and advanced several bills. Senate Bill 198, relating to operations of the Office of the Attorney General, was described as a cleanup measure with seven changes, including allowing the AG’s office to handle child support employee background checks and fingerprinting, updating child support guideline commission references, clarifying control of constitutional officers’ records in multistate litigation, setting a 10-year statute of limitations for certain consumer protection matters, streamlining administrative hearing appeals, and changing representation of the professional geologist board. After questions about the administrative hearing appeal language, the committee passed the bill 9-0. The committee then passed Senate Bill 323, which would require subpoenas for medical records to be served at least 14 days before production. President Stivers said the bill is intended to give health care providers reasonable time to comply with HIPAA, redact records, and avoid motions to quash when subpoenas are served on short notice. A question about appeal deadlines was answered by noting the bill would not affect the common 10-day motion-to-reconsider rule. The bill passed 9-0. Senate Bill 66, as amended by committee substitute, was also passed 9-0. The substitute addressed DUI-related issues, including preserving certain driving records for 10 years, removing urine screens from the bill, adding fentanyl and other substances to the per se controlled-substances DUI list, and clarifying that a preliminary breath test may be refused and that officers should advise drivers of that right. The committee also passed Senate Bill 221, a model-law bill making the knowing purchase, sale, transfer, or offer to sell human remains for consideration a Class D felony; members asked about whether it could affect older medical specimens or fetal remains, and sponsors said the bill is aimed at remains authorized for final disposition through cremation or burial. That bill passed 8-0. Finally, Senate Bill 312, concerning court-ordered transports in mental health cases, was presented by court security and sheriff’s association representatives. They said the bill clarifies that sheriffs may use court security staff to monitor and transport individuals undergoing 202A mental health evaluations, addressing staffing shortages and existing practice. The committee passed the bill 8-0. The committee then began hearing Senate Bill 333 on body armor grants, with the Attorney General’s office testifying that the bill would transfer administration of the Law Enforcement Protection Program to the AG and align it with the office’s existing body armor grant program, but the transcript cuts off before any vote on that measure.

Transcript Highlights:

• in an instance of suspected or actual criminal exposure to controlled substances.
• House Bill 473 offers a simple but critical fix, expanding the statute to cover all controlled substances
• So, so I'm looking at this bill has a exposing children to controlled substances.
• You know, the fact that it's exposing children to a controlled substance, if that's the case, then I
• I understand the fact that it's protected by the exposing of a controlled substance is my first factor

Keywords: 1191, senate, all

Transcript Highlights:

• There is no crime if there is no controlled substance.
• Substance Act, One of the issues we've got with our Controlled Substance Act is that any concentrate
• And if these sorts of controls already exist at the federal controlled-substance level, right?
• That's what the Controlled Substances Act is.
• That's what the Controlled Substances Act is.

Summary: The House Committee on Public Health heard House Bill 5, a proposal to ban THC products outside the Texas Compassionate Use Program while allowing non-intoxicating CBD and CBG products under tighter regulation. Chair Van Deaver gave a lengthy background on the 2018 federal Farm Bill and Texas’s 2019 hemp law, arguing that the lack of guardrails allowed a large, unregulated THC market to develop. HB 5 would impose licensing fees, product registration, testing and inspection requirements, and restrictions intended to keep products away from children. Invited witnesses from law enforcement strongly supported the bill. Steve Dye of the Texas Police Chiefs Association and Brian Hawthorne of the Sheriffs’ Association of Texas argued that THC consumables are widely mislabeled, often far more potent than advertised, and linked to youth access, impaired driving, and organized crime. Both said regulation would be ineffective and would amount to legalization, while a ban would be easier for officers to enforce. They also emphasized support for the Texas Compassionate Use Program and said medical THC should remain available. Dr. Peter Stout of the Texas Association of Crime Lab Directors and Alice Amelot of Texas DPS testified as resource witnesses about forensic testing. They said current lab resources are already stretched thin, that quantitative testing for THC and related cannabinoids is expensive and time-consuming, and that a ban would simplify enforcement because labs could focus on presence/absence testing rather than concentration. Amelot said DPS labs are neutral on the bill but explained that mislabeled products and inaccurate certificates of analysis are common. Committee members asked about traffic safety, impairment, youth use, and the costs of enforcement and lab testing; witnesses repeatedly said the bill would reduce complexity for law enforcement but that any approach would still require more resources for labs.

Transcript Highlights:

• Before this, there was methadone, and methadone is highly controlled, hard to get at, daily dosages when
• Before this, there was methadone, and methadone is highly controlled, hard to get at, daily dosages when
• It is a life or death bill for many people who are seeking substance use disorder treatment and don't
• Thank you. methadone is highly controlled, hard to get at, daily dosages when you got to get in a car
• "There's such a need for substance use treatment in this state and in this country.

Keywords: 1183, house

Summary: House File 4493 would authorize pharmacists to initiate, prescribe, administer, and dispense certain drugs for opioid use disorder, especially buprenorphine/Suboxone. Representative Baker said the bill is intended to save lives by giving people immediate access to treatment at the moment they seek help, rather than making them wait for a doctor’s appointment or navigate more cumbersome methadone access. He emphasized that pharmacists are widely accessible, including in greater Minnesota, and that optional training would support safe prescribing. Representative Bierman spoke in strong support, calling the measure a life-or-death step forward for people with substance use disorder and noting that many people do not receive treatment when they need it. He said he initially had concerns but Baker listened to his suggested changes and worked with him and bill drafters, which helped address those concerns. Bierman also referenced the ongoing fentanyl crisis and encouraged members to learn more from displays honoring overdose victims. Baker closed by sharing personal remarks about losing his son to addiction and describing how limited treatment options were at that time. He said the new federal change allowing pharmacist training makes the bill timely and urged members to support it. After discussion, the House took a roll call vote and passed the bill 134-0, with the title agreed to.

Transcript Highlights:

• And because of that abuse, [they] became substance dependent; substance dependency became sex trafficking
• K2 is a synthetic marijuana or substance.
• substance because it's kind of different.
• of substance because it's kind of different.
• Substance abuse, AA/NA-type courses, behavioral therapy, mental health services, substance abuse treatment

Keywords: 995, all

Summary: The commission met to continue its review of the county sheriffs’ role in corrections, reentry, and public safety. After approving the prior meeting minutes, the sheriffs completed a lengthy presentation describing how their offices provide regional jail services, women’s programming, mental health and substance use treatment, reentry support, community partnerships, and auxiliary public safety functions such as BCI work, TRIAD, Meals on Wheels, and event support. They emphasized that services are tailored to local needs, that women’s facilities are designed to keep mothers close to family and support reunification, and that programming, housing, and job placement are central to reducing recidivism. They also discussed challenges including K2/synthetic drugs in facilities, gang classification and separation, and the difficulty justice-involved people face obtaining IDs and birth certificates, especially for people from Puerto Rico. Commission members generally praised the sheriffs’ work and asked for more detail on how regional women’s facilities operate, how community-provider cuts might affect reentry services, how no-cost phone/tablet communication is balanced against programming time, and what the most essential programs are if funding is reduced. The sheriffs said programming must come first, identified mental health, substance use treatment, domestic violence programming, and housing/job placement as critical, and explained that community organizations and the Registry of Motor Vehicles are key partners in reentry. They also described their approach to gang management through classification, separation, and information sharing, and noted that the Registry has become more flexible but Real ID requirements have made documentation barriers more significant. The commission chair stressed that the purpose of the study is collaboration and improving system performance, not an adversarial effort against the sheriffs or a decarceration debate. Members noted that future meetings would hear from probation in June and the Department of Correction in July, and that the commission would continue gathering information before deciding on next steps. The meeting ended with a motion to adjourn, which passed unanimously.

Transcript Highlights:

• And also the question of whether it should be classified as a controlled substance and appropriate penalties
• And the Substances.
• It includes the substance use treatment community.
• And so this company was the one that basically developed the control.
• So it was this strange relationship between the company that develops the controls against which substances

Keywords: 995, all

Summary: The special commission on xylazine met virtually to review and discuss the first draft of its final report. Chair Mindy Domb opened the meeting, confirmed quorum, and the commission approved the minutes from its December 11 public meeting. Staff then walked commissioners through the proposed report structure, including background on xylazine as both an FDA-approved veterinary drug and an illicit drug supply contaminant, as well as appendices for public meeting materials and public resources. The commission discussed findings and recommendations for several working groups. For oversight and enforcement, members focused on licit versus illicit sources of xylazine, noting that the illicit supply is typically obtained through online vendors rather than diverted from veterinary use. Recommendations included better storage and reporting practices in authorized settings, review of manufacturing and distribution information, and focusing enforcement on fentanyl trafficking and large-scale xylazine importation rather than personal possession. Commissioners also discussed whether xylazine should remain in Schedule 6 or be subject to additional penalties, and several members emphasized the need for coordination, information-sharing, and possibly a DPH task force or advisory body to monitor emerging drug threats. For outreach and treatment, staff summarized strong existing programs such as drug checking, wound care education, naloxone distribution, mobile and low-threshold care, and self-directed wound kits, while noting gaps including the lack of an FDA-approved reversal agent for xylazine, difficulty distinguishing xylazine from other exposures, and uneven access by geography, insurance, and audience. Commissioners stressed the need for provider education, including physicians, nurses, pharmacists, family support networks, and first responders, and for clear guidance on wound care and when more intensive treatment is needed. The education and training section identified first responders, clinicians, non-clinicians, and people who use drugs and their families as key audiences for tailored, stigma-free materials, with emphasis on real-time, centralized data, naloxone and breathing support, recognition of overdose versus xylazine exposure, and adapting materials as the drug supply changes. The meeting ended with discussion of next steps: staff will circulate a revised draft by March 2, the commission will meet again on March 9 to consider the report and recommendations, and an additional late-March meeting was reserved if needed before the statutory deadline.

Bills: HB1974, HB1853, HB1973, HB1574, HB2619, HB1966, HB1643, HB1671, HB2558, HB1854, HB2173, HB1575, HB2229, HB1535, HB1978, HB2508, HB1549, HB2187, HB1550, HB1977, HB2314, HB1871, HB2319, HB1591, HB1858, HB1898, HB2372, HB1765, HB2012, HB1706, HB1962, HB1963, HB1975, HB2009, HB2083, HB2224, HB1877, HB1959, HB1626, HB1665, HB2488, HB2456, HB2548, HB2207, HB1832, HB2079, HB1985, HB1618, HB2486, HB2242, HB2045, HB1703, HB2236, HB2480, HB1976, HB2287, HB2288, HB1777, HB276, HB1660, HB1676, HB1605, HB1751, HB1967, HB2383, HB2340, HB1946, HB2268, HB1950, HB2156, HB2118, HB1859, HB1863, HB1996, HB2114, HB2423, HB2429, HB2475, HB2534, HB2545, HB1813, HB1941, HB2474, HB2583, HB1576, HB1886, HB1939, HB2540, HB2590, HB2000, HB2163, HB2386, HB1691, HB1680, HB2516, HB1993, HB2442, HB1510, HB1958, HB1692

Keywords: HB1974, hearing loss, audiology, audiologist, hearing screening, hearing aids, cochlear implants, tele-audiology, communication access, assistive technology, speech-language pathology, deafness, hard of hearing, public health, kupuna, keiki, dementia, cognitive decline, fall prevention, State Health Planning and Development Agency

Transcript Highlights:

• In 2018, the federal government allowed hemp products under the Controlled Substances Act.
• Medical Cannabis Control and Regulation. Medical Cannabis Control and Regulation.
• Substances Act.
• <00:49:53.359> Um<00:49:54.480> there<00:49:54.720> is controlled substances
• Um there is controlled substances act.

Bills: HB1974, HB1853, HB1973, HB1574, HB2619, HB1966, HB1643, HB1671, HB2558, HB1854, HB2173, HB1575, HB2229, HB1535, HB1978, HB2508, HB1549, HB2187, HB1550, HB1977, HB2314, HB1871, HB2319, HB1591, HB1858, HB1898, HB2372, HB1765, HB2012, HB1706, HB1962, HB1963, HB1975, HB2009, HB2083, HB2224, HB1877, HB1959, HB1626, HB1665, HB2488, HB2456, HB2548, HB2207, HB1832, HB2079, HB1985, HB1618, HB2486, HB2242, HB2045, HB1703, HB2236, HB2480, HB1976, HB2287, HB2288, HB1777, HB276, HB1660, HB1676, HB1605, HB1751, HB1967, HB2383, HB2340, HB1946, HB2268, HB1950, HB2156, HB2118, HB1859, HB1863, HB1996, HB2114, HB2423, HB2429, HB2475, HB2534, HB2545, HB1813, HB1941, HB2474, HB2583, HB1576, HB1886, HB1939, HB2540, HB2590, HB2000, HB2163, HB2386, HB1691, HB1680, HB2516, HB1993, HB2442, HB1510, HB1958, HB1692

Keywords: HB1974, hearing loss, audiology, audiologist, hearing screening, hearing aids, cochlear implants, tele-audiology, communication access, assistive technology, speech-language pathology, deafness, hard of hearing, public health, kupuna, keiki, dementia, cognitive decline, fall prevention, State Health Planning and Development Agency

Transcript Highlights:

• Controlled Substances Act defines an abuse unit, penalty group 1, a substance such as LSD, based on how
• It's what we do with all the adulterants and diluents; they are part of the weight in controlled substances
• It's what we do with all the adulterants and diluents; they are part of the weight in controlled substances
• It's what we do with all the adulterants and diluents; they are part of the weight in controlled substances
• Because of the psychological power control will, psychological power control will, the cycles of abuse

Summary: The Committee on Criminal Jurisprudence met with a quorum and heard a series of Senate bills, generally receiving sponsor explanations and, in most cases, no public testimony. SB 2595 would create a Class B misdemeanor for harassing, threatening, or intimidating someone while intentionally concealing identity with a mask, with broad affirmative defenses for legitimate mask use; SB 1980 would increase penalties for assaulting peace officers, parole officers, and community supervision officers and add related presumptions and interference protections; and SB 1896 would require magistrates to issue emergency protective orders in certain family violence, sexual assault, stalking, and aggravated cases, with law enforcement required to provide needed information. All three were left pending. The committee also heard SB 955, which increases trafficking of persons from a second-degree to a first-degree felony when the victim was recruited from a correctional facility, and SB 614, which would let the Texas Forensic Science Commission refer dismissed complaints to the Office of Capital and Forensic Writs when they reference a prior FSC report; both were left pending. Members then heard several forensic and criminal procedure bills. SB 1372 would resolve a discovery/access conflict involving the DPS crime lab portal by limiting portal access to defense attorneys rather than defendants directly, prompting questions from members about access for pro se defendants; DPS’s chief crime lab witness testified neutrally. SB 1936 would change the LSD “abuse unit” definition for unmarked/unperforated paper from a square-measurement method to a 10-milligram weight standard, and SB 1937 would require a subject matter expert from the testing lab to participate in pretrial meetings in capital cases involving biological evidence to help identify viable testing and conserve resources. SB 2580 would lower the population threshold for sheriff’s departments to independently use tracking equipment and access certain communications from 3.3 million to 500,000, expanding the authority beyond Harris County; it was described as a public safety and emergency response measure and left pending. The committee also considered SB 2798, which would extend the statute of limitations for certain financial crimes from three years to seven years, with testimony from a Montgomery County assistant district attorney supporting the change because fraud is often discovered late. SB 1099 would increase penalties for felony offenses committed by undocumented or unauthorized aliens, but drew strong opposition from the Texas Civil Rights Project, which argued immigration is a federal matter and that the bill would create difficult and potentially unfair status determinations for local courts; members raised concerns about the lack of an expert-testimony requirement. SB 1278 would create an affirmative defense to prostitution prosecution for trafficking victims compelled by their traffickers to commit the conduct, and testimony from advocates and a member’s personal account emphasized the coercive, traumatic nature of trafficking; members discussed whether the defense should be narrower or framed as mitigation, and the bill was left pending. Finally, SB 127 would extend the statute of limitations for failure to report or conceal child abuse, with members discussing mandatory reporting duties and the need to allow more time for delayed discovery of cover-ups; it too was left pending before the committee adjourned.

Transcript Highlights:

• Of the case that all 300 pounds are, in fact, a controlled substance.
• a reasonable doubt what that controlled substance is.
• not be... ...be a controlled substance.
• These sorts of controls already exist at the federal level, like, controlled substance regulations, right
• That's what the Controlled Substances Act is.

Bills: HB5

Keywords: hemp, cannabinoids, regulation, occupational licenses, consumable products, marketing, criminal offenses, labeling requirements, health and safety, 997, house, all

Transcript Highlights:

• the Massachusetts cannabis Control the Massachusetts cannabis Control Commission<00:09:40.560>
• the office of medical cannabis control the office of medical cannabis control and<00:10:50.240><
• Substances Act.
• <01:57:42.000> Substances<01:57:42.560> Act<01:57:42.760> so from the Controlled
• Substances Act so from the Controlled Substances Act so it's<01:57:43.079> no<01:57:43.239>

Keywords: 910, house, all

Transcript Highlights:

• to these substances.
• Lumpkin talked about just a minute ago with the 38.11: alcoholic beverages, controlled substances or
• Lumpkin talked about just a minute ago with the 38.11, which is alcoholic beverages, controlled substances
• We're always recruiting, and that's going to give us additional help to control what we control, which
• substance?

Keywords: 1185, senate, all

Transcript Highlights:

• Control, which is DTSC, in 2021.
• Control, and certainly with the board, since its inception.
• management of hazardous substances.
• Some of their products include disinfectants, cleaning products, and pest control solutions.
• Some of their products include disinfectants, cleaning products, and pest control solutions.

Summary: The joint oversight hearing focused on DTSC’s implementation of SB 158 reforms, including enforcement, community engagement, fee stability, the hazardous waste management plan, permitting backlogs, and the Safer Consumer Products program. Senators and Assembly members emphasized protecting overburdened communities and asked how DTSC and the Board of Environmental Safety are using their authority to improve accountability, reduce delays, and address hazardous waste facilities and consumer product chemicals. The hearing also included discussion of extended producer responsibility programs and whether DTSC can support them more efficiently, including through coordination with CalRecycle. DTSC Director Katie Butler said the department is now more transparent, accountable, and fiscally stable, citing stronger enforcement actions, an interactive inspections map, expanded community outreach, and emergency response work on the Los Angeles wildfire cleanup. She said DTSC has made progress on fee reform, the hazardous waste management plan, cleanup grants, permit renewals, and safer consumer products rulemaking, including adding microplastics to the candidate chemical list. Board Chair Andrew Rakestraw said the board has held multiple public meetings and hearings, is working on fee rates and performance metrics, and is revising the hazardous waste management plan after public comment, including removing a proposal to send certain contaminated soil to municipal landfills. He also noted remaining concerns about fee structure, permit delays, and the pace of the safer consumer products program. Public witnesses offered sharply different views. A representative of the California Council for Environmental and Economic Balance said SB 158 reforms have improved permitting and transparency, but urged more attention to risk-based decision-making, reduced duplication, and possible General Fund support for plan implementation rather than relying only on fees. Earthjustice argued DTSC remains too slow and that communities continue to suffer from long-delayed permits and weak protections, urging the Legislature to take a more active role and to prioritize eliminating hazardous substances rather than minimizing costs. Committee members pressed the witnesses on permit renewals, community impacts, and the pace of the safer consumer products program, while DTSC defended its progress and said further legislative collaboration may be needed on hazardous waste management and emerging waste streams.

Transcript Highlights:

• Senate Bill 452, Senate Draft 1, relating to the Uniform Controlled Substance Act.
• This bill is the annual controlled substances update. It does a number of important things.
• This bill is the annual controlled substances update. It does a number of important things.
• Senate Bill 1452, Senate Draft 1, relating to the Uniform Controlled Substances Act.
• <02:18:43.679> substance controlled substance controlled substance act<02:18:46.080> we

Keywords: 910, house, all

Summary: The House Committee on Judiciary and Hawaiian Affairs heard Senate Bill 1322, SD2, HD1, a comprehensive measure revising Hawaii’s mental health code. The bill would clarify emergency transportation, examination, and hospitalization procedures for people who may be mentally ill or suffering from substance abuse and deemed imminently dangerous, expand notice requirements, allow certain information-sharing for assisted community treatment petitions, and add liability protections for emergency responders and providers. The Department of the Attorney General supported the bill as a collaborative update to the law, while the Department of Health asked for a copy of provider-generated emergency transport documentation within five days for data and planning purposes. Testimony was sharply divided. Queen’s Health System, Hawaiʻi Pacific Health, HHSC, and the Institute for Human Services supported the measure or parts of it but requested amendments, including clarifying whether a second psychiatric exam is required, restoring a 72-hour rather than 48-hour stabilization window, and adjusting where patients are taken when an MEO cannot be reached. The ACLU of Hawaiʻi strongly opposed the bill, arguing it weakens due process and civil liberties, especially around involuntary commitment, assisted community treatment, emergency transport by police, and reduced procedural safeguards; it urged the committee to hold the bill and consider an interim working group. Louie E.K. of the Hawaiʻi Disability Rights Center also opposed the bill, focusing on immunity from negligence, the use of police for transport, and the reduction of a three-provider review to one in state-hospital treatment orders. Other testimony included support from an individual who said the bill could improve mental health care delivery amid provider shortages, and a comment from Hawaiʻi Health and Harm Reduction Center warning that the substance use portion of the bill lacks evidence of effectiveness and could be misused. In response to committee questions, the Attorney General’s office said the measure was developed with input from multiple stakeholders, including state agencies, hospitals, the ACLU, HHSC, and IHS, and that it aims to make assisted community treatment more accessible and effective by streamlining the legal process and improving consequences for noncompliance. No vote or final action was taken during the portion of the meeting provided.

Transcript Highlights:

• certain controlled substances such as opioids through a database.
• substance abuse problems, and provides evidence of multiple providers prescribing controlled substances
• substances obtain a controlled substance registration from a licensing central authority, often Obtain
• a controlled substance registration from a licensing central authority, often that state's pharmacy
• We're hoping that House Bill 2434, the controlled substance prescription monitoring program bill, will

Keywords: 1182, all

Summary: The committee conducted sunset reviews for the Arizona State Board of Pharmacy, the State Board of Nursing, the Arizona Board of Occupational Therapy Examiners, and the Arizona Regulatory Board of Physician Assistants. The Auditor General’s reports praised each board for timely licensing in some areas but identified recurring problems with complaint investigations, public safety oversight, fee analysis, records/documentation, and internal controls. For Pharmacy, the main concerns were weak enforcement of controlled substances prescription monitoring program (CSPMP) requirements and slow complaint resolution; the board said it had implemented some recommendations, was pursuing a new database vendor, and supported legislation to strengthen CSPMP enforcement. For Nursing, the audit found a large and growing backlog of complaints and repeated delays in resolving cases; the executive director said the board was under-resourced and requested 28 additional investigative positions, while nursing stakeholders supported process reforms and cited a bill to improve timelines and fairness. For Occupational Therapy, the audit focused on missing or poorly documented fingerprint clearance card checks, delayed action on a serious criminal-charge disclosure, and other compliance issues; the board said it had accepted and was implementing all recommendations, including new procedures and rulemaking. For Physician Assistants, the audit found weak oversight by the executive director, extensive delays in complaint handling, and an incentive-pay system that did not align with key performance goals; the board said it had already made structural changes, was improving tracking and IT systems, and planned to continue implementing recommendations. After discussion and testimony from board officials, public members, and nursing stakeholders, the committee voted to continue the Arizona State Board of Pharmacy for six years until July 1, 2032, the State Board of Nursing for four years until July 1, 2031, the Arizona Board of Occupational Therapy Examiners for four years until July 1, 2030, and the Arizona Regulatory Board of Physician Assistants for a continued term with statutory changes (the transcript includes the board review and related discussion, but the final motion text for the physician assistants board is not fully captured in the excerpt). The votes on the first three continuations were approved by roll call, with members generally supporting continuation while expressing concern about complaint backlogs and the need for reforms.

Transcript Highlights:

• be looking at how the changes we passed last year to the laws addressing both mental health and substance
• In addition to strengthening the controls in the areas noted, In addition to strengthening the controls
• There was, in some instances, a lack of control.
• In some instances, there was a lack of control.
• The report, the significant findings report, gets into those baselines for controls.

Summary: The subcommittee heard two Department of Children and Families implementation updates on measures passed in prior sessions. First, DCF reviewed House Bill 633, which increased oversight of behavioral health managing entities through biennial independent audits, standardized claims-based reporting, and new monthly outcome dashboards. The department said it had awarded the inaugural audit to Ernst & Young, found no significant waste, fraud, or abuse, but identified process risks involving financial controls, claims validation, data access, and system access controls. DCF also described its transition to standardized behavioral health coding and said the new public dashboard of 11 measures is posted on its website, though members asked for easier access and for hard copies of the audit report. Members asked about how the department distinguishes Medicaid-covered services from department-funded services, how duplicate payment risks are being addressed, and whether the new reporting and audit requirements would improve oversight without disrupting services. DCF said it is the payer of last resort for uninsured or underinsured individuals, that some overlap with Medicaid is expected because Medicaid does not cover all behavioral health services, and that new claims edits and cross-checks are being built into the system. The department also said it had not found significant negative feedback from providers and that the new requirements are intended to improve transparency and accountability. DCF then updated the committee on Senate Bill 7012, covering human trafficking data collection, domestic violence center certification, limited background-screening exemptions, expanded recruitment for child welfare staff, subcontractor liability protections, a four-year treatment foster care pilot, case management efficiency recommendations, and a statewide study of residential bed capacity for child victims of commercial sexual exploitation. The department said several items are already complete or underway, including limited exemptions in the screening clearinghouse, while others are in procurement or rulemaking. It identified Circuits 4 and 12 as the treatment foster care pilot sites and said the pilot will launch in January 2026. Members questioned recruitment metrics, pilot timing, and report deadlines; the department said final reports are expected by January and that some dates were flexible because of procurement and implementation timelines. The meeting ended after the presentations and questions, and the subcommittee adjourned.

Transcript Highlights:

• However, not all podiatrists prescribe controlled substances, so this bill removes that requirement if
• HOWEVER NOT ALL PODIATRISTS  PRESCRIBE CONTROLLED SUBSTANCES SO  237 THIS BILL REMOVES THAT
• So what this PCS does is say if you are a podiatrist and you want to prescribe controlled substances,
• 254 IS SAY IF YOU ARE A PODIATRIST AND YOU WANT TO  PRESCRIBE CONTROLLED SUBSTANCES YOU  255
• HB 169 updates injection therapy and prohibits use of controlled substances, antibiotics, vaccines, Botox

Summary: The committee met with a quorum present and heard a series of health care-related bills, with Chair Tuck emphasizing respectful debate and noting that all bills on the agenda would be voted on that day. The first measure, HB 743, would give the Attorney General authority to investigate and bring civil actions against health care practitioners who violate Florida’s ban on gender-affirming care for minors, and would make aiding or abetting such conduct a third-degree felony. Supporters said it closed loopholes and protected minors and parental rights, while opponents argued it was vague, overbroad, and could chill lawful care and professional judgment. The bill passed 13-4 and was reported favorably. The committee then unanimously approved PCS for HB 567, which narrows a continuing-education requirement for podiatrists so only those who prescribe controlled substances must take the related two-hour course. It also unanimously approved HB 439, allowing chiropractors, under specified training and certification requirements, to inject vitamins and nutrients while continuing to prohibit intravenous injections. The committee also passed HB 1235 to enter Florida into the respiratory care interstate compact, and HB 1237, a linked public-records/public-meetings exemption needed to implement that compact; both measures were supported as workforce and access-to-care bills and passed without opposition. Later, the committee approved PCS for HB 809, which addresses temporary physician certificates in areas of need and aims to prevent doctors from losing the ability to practice when area designations change. Members asked about licensure pathways and the effect of federal or board designation changes, and supporters framed the bill as protecting continuity of care in underserved communities. The committee also unanimously passed HB 1347 to align clinical laboratory personnel licensing with federal CLIA standards amid staffing shortages, and HB 1515, a public-records exemption tied to a uterine fibroid research database. Finally, the committee approved HB 169 updating acupuncture statutes, including terminology changes and limits on injection therapy, and HB 1021, Representative Young’s first bill, allowing qualified hospital pharmacists in Level I and II trauma centers to administer emergency medications at a physician’s direction during life-threatening situations. HB 1021 drew the most questions, mainly about scope, definitions, and who could authorize the pharmacist, but after a technical amendment it passed unanimously. All remaining bills were reported favorably, and the meeting adjourned after the final vote.

Transcript Highlights:

• Human right to control our bodies, lives, and futures.
• Are empowered to control their health, bodies, and destinies.
• County's Substance Abuse Prevention and Control Program, to testify in support. Thank you, Chair.
• Gary Sign, the Director of the Substance Abuse Prevention and Control Program with the Los Angeles County
• in lowering their risk from substances, are exactly the individuals that we need to be engaging in substance

Summary: The Assembly Health Committee met on April 8 and heard a long series of bills, beginning with AB 54 on medication abortion access. The author and supporters, including the Attorney General’s office and reproductive justice advocates, said the bill would protect California’s medication abortion supply chain and shield providers and manufacturers from civil, criminal, and professional liability. Opponents from the California Family Council argued the bill removes safeguards and increases risks. The bill was moved forward on a committee motion. The committee then heard several reproductive and public health measures, including AB 551 to create a pilot program supporting emergency departments in providing reproductive health services, AB 260 to protect medication abortion access and telehealth, AB 309 to remove sunset dates on laws allowing pharmacy syringe sales and lawful possession of sterile syringes, AB 536 to preserve colorectal cancer screening coverage if federal guidelines are challenged, AB 804 to make housing support services a Medi-Cal benefit, AB 594 to address student health insurance billing and transparency, AB 836 to study and expand the midwifery workforce, AB 1418 to collect data on health coverage for eligible employees, and AB 1500 to maintain and expand the abortion.ca.gov information site. Supporters emphasized access, preventive care, workforce shortages, and public health benefits, while opponents raised concerns about abortion, syringe distribution, and the focus of state resources. Most measures were advanced by committee vote, with roll calls showing broad support and a few no votes from members on some bills. The final bill discussed in the transcript was AB 1037, which would update substance use disorder laws to reflect evidence-based, harm-reduction approaches and remove barriers to treatment. The author and supporters described it as a compassionate response to overdose and treatment access problems, while law enforcement opposition argued it would encourage drug use and endanger communities. The transcript cuts off during testimony on AB 1037, so no final committee action on that bill is shown in the provided text.